NCT05654207 WeCare: A System of Care for Black Youth
| NCT ID | NCT05654207 |
| Status | Recruiting |
| Phase | — |
| Sponsor | New York University |
| Condition | Suicidal Ideation |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,200 participants |
| Start Date | 2024-04-08 |
| Primary Completion | 2027-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,200 participants in total. It began in 2024-04-08 with a primary completion date of 2027-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall goal of this study is to respond to the urgent need for an effective suicide prevention strategy for Black youth by examining the effectiveness of a systems-level strategy to recognize and respond to suicide risk among Black adolescents who present to emergency departments (EDs). The proposed strategy, WeCare, combines combines three components: (1) universal screening using the Computerized Adaptive Screen for Suicidal Youth (CASSY), (2) a brief intervention designed for Black youth with elevated suicide risk in for ED settings, Connections for Safety (CFS), that combines safety planning and strategies to support linkage to outpatient mental health services, and (3) supportive text messages to youth and parent/caregivers for six weeks following the youth's ED visit. Study objectives are (1) to integrate input from multiple stakeholders to inform and facilitate WeCare implementation, and (2) to use a hybrid one effectiveness-implementation design to evaluate its effectiveness.
Eligibility Criteria
Inclusion criteria adolescent and parent/guardians: * Adolescents aged 12-17 years and their parents or guardians, and adolescents 18-19 years who have the option for their parent or guardian to participate * Having a parent/caregiver present in the ED to consent or available to consent remotely (12-17 year olds, only) * Having a cellular phone with text messaging capacity * Adolescent able to speak English, and understand study questions * Parents able to consent in English, Spanish, French or Creole * Meet screening criteria Exclusion criteria adolescent and parent/guardians: * Adolescent is medically unstable * Adolescent present with severe cognitive impairment * Parents are not present in the ED, unable to consent remotely, and not able to give consent in either English, Spanish, French or Creole (12-17 year olds, only) * Adolescent does not have access to cellular phone * Adolescents active in mental health treatment (e.g., seen a therapist, social worker, or mental health provider in the last week)
Contact & Investigator
Michael A Lindsey, PhD
PRINCIPAL INVESTIGATOR
New York University
Frequently Asked Questions
Who can join the NCT05654207 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 19 Years, studying Suicidal Ideation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05654207 currently recruiting?
Yes, NCT05654207 is actively recruiting participants. Contact the research team at michael.lindsey@nyu.edu for enrollment information.
Where is the NCT05654207 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT05654207 clinical trial?
NCT05654207 is sponsored by New York University. The principal investigator is Michael A Lindsey, PhD at New York University. The trial plans to enroll 2,200 participants.